Sangamo shares surge on Roche gene therapy withdrawal
Shares of Sangamo Therapeutics experienced a significant surge, climbing as much as 36%, following the announcement that pharmaceutical giant Roche has discontinued its gene therapy program for h...
BofA upgrades Ambarella to ‘neutral’
Investing.com --BofA Securities upgraded Ambarella Inc (NASDAQ: AMBA ) to “neutral” from “underperform,” with the price target raised to $80 from $65, on expected g...
Loop Capital upgrades Netflix to 'buy' on subscriber growth, content pipeline
Investing.com --Loop Capital upgraded Netflix Inc (NASDAQ: NFLX ) to "buy" from "hold," given its robust subscriber growth, mid-teens revenue growth, and a strong slate of upcoming con...
